- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06045234
Temporal Variation of the Exposure to Pesticides in the Employees of the Limoges University Hospital (VESTAL)
Study Overview
Detailed Description
The general population is exposed to pesticides through the ingestion of food and water. The presence of pesticides in human urine has been demonstrated in numerous studies. Conventionally, biological monitoring studies use an undifferentiated urine sample or the first morning urine. The reliability of measuring a single-point urinary concentration to represent the profile of pesticide exposure in individuals over time is, however, questionable. Rare studies reporting intra-individual outcomes of pesticide exposure have been conducted in specific populations, such as children and pregnant women.
It is proposed to carry out a descriptive biomonitoring study of the urinary concentration of approximately 320 pesticides in a sample of the general population. Among these, the study will focus on glyphosate.
The originality of our study is:
- (i) Exploration of exposure to the main pesticides in a sample of 300 people by measuring urinary concentration by specific and sensitive methods of LC-MS/MS and GC-MS/MS; These 300 subjects will be hospital staff of the Limoges University Hospital.
- (ii) Exploration of the intra-individual variability of exposure by repeating measurements in urine samples taken over a 24-hour period and/or several times over the course of a week;
- (iii) Determination of the frequency of subjects who have potentially been exposed to doses higher than the acceptable daily intake (in particular for glyphosate) (iv) The association of these exposure values with data from a self-administered questionnaire in order to identify the determinants of this exposure
- (V) Estimating the predictability/reliability of a single urine sample to represent this exposure of individuals/populations over time.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Limoges, France, 87042
- CHU de Limoges
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult 18 years and over.
- Employed by the University Hospital of Limoges.
- Having consented to participate in the study after being informed.
Exclusion Criteria:
- Adult with a professional activity during which he is required to handle or come into contact with glyphosate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Pesticide measurement
|
Among the 300 people recruited:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
glyphosate overconsumption
Time Frame: 1 week
|
Proportion of individuals with an estimated daily consumption of glyphosate greater than the acceptable daily intake of glyphosate
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identification of determinant of exposure to glyphosate
Time Frame: 1 week
|
Proportion of individuals with a daily consumption of glyphosate greater than the acceptable daily intake according to socio-demographic determinants(age, sex, profession and socio-professional category)
|
1 week
|
|
Identification of determinant of exposure to glyphosate
Time Frame: 1 week
|
Proportion of individuals with a daily consumption of glyphosate greater than the acceptable daily intake according to lifestyles (city center, peri-urban, rural )
|
1 week
|
|
Identification of determinant of exposure to glyphosate
Time Frame: 1 week
|
Proportion of individuals with a daily consumption of glyphosate greater than the acceptable daily intake according to proximity to agricultural activities
|
1 week
|
|
Identification of determinant of exposure to glyphosate
Time Frame: 1 week
|
Proportion of individuals with a daily consumption of glyphosate greater than the acceptable daily intake according to use of glyphosate at home
|
1 week
|
|
Identification of determinant of exposure to glyphosate
Time Frame: 1 week
|
Proportion of individuals with a daily consumption of glyphosate greater than the acceptable daily intake according to dietary habits
|
1 week
|
|
Coefficient of variation of the glyphosate concentrations
Time Frame: 1 week
|
Calculation of the coefficient of variation of the glyphosate concentrations measured 3 times over a period of 24 hours
|
1 week
|
|
Intra-individual variability of urinary glyphosate concentrations
Time Frame: 1 week
|
Comparison of the average GLP concentrations measured on 3 occasions (at sunrise, in the middle then at the end of the day) over a period of 24 hours.
|
1 week
|
|
Impact of urine sample collection schedule on glyphosate concentration measurement
Time Frame: 1 week
|
According to the methodology proposed by Wang et al. : a linear mixed-effects model to determine which measure produces the best estimate of exposure; itself obtained by calculating the mean of the observed values.
|
1 week
|
|
Identification of determinants of exposure to a panel of around 320 pesticides
Time Frame: 1 week
|
Proportion of subjects with a detectable concentration among the 320 pesticides measured by specific LC-MS and GC-MS methods and prevalence of individuals with a detectable concentration according to socio-demographic determinants
|
1 week
|
|
Identification of determinants of exposure to a panel of around 320 pesticides
Time Frame: 1 week
|
Proportion of subjects with a detectable concentration among the 320 pesticides measured by specific LC-MS and GC-MS methods and prevalence of individuals with a detectable concentration according to lifestyles
|
1 week
|
|
Identification of determinants of exposure to a panel of around 320 pesticides
Time Frame: 1 week
|
Proportion of subjects with a detectable concentration among the 320 pesticides measured by specific LC-MS and GC-MS methods and prevalence of individuals with a detectable concentration according to proximity to agricultural activities
|
1 week
|
|
Identification of determinants of exposure to a panel of around 320 pesticides
Time Frame: 1 week
|
Proportion of subjects with a detectable concentration among the 320 pesticides measured by specific LC-MS and GC-MS methods and prevalence of individuals with a detectable concentration according to use of glyphosate at home
|
1 week
|
|
Identification of determinants of exposure to a panel of around 320 pesticides
Time Frame: 1 week
|
Proportion of subjects with a detectable concentration among the 320 pesticides measured by specific LC-MS and GC-MS methods and prevalence of individuals with a detectable concentration according to dietary habits
|
1 week
|
|
Intra-individual variability of urinary 320 pesticides concentrations
Time Frame: 1 week
|
Calculation of the coefficient of variation of the concentrations of each of the pesticides (expressed in µg/L or µg/g of creatinine) measured 3 times (at sunrise, in the middle and then at the end of the day) over a period of 24 hours
|
1 week
|
|
Impact of urine sample collection schedule on 320 pesticides concentration measurement
Time Frame: 1 week
|
Comparison of the average concentrations of each of the pesticides measured on 3 occasions (at sunrise, in the middle and then at the end of the day) over a period of 24 hours.
According to the methodology proposed by Wang et al.: a linear mixed-effects model to determine which measure produces the best estimate of exposure; itself obtained by calculating the mean of the observed values.
|
1 week
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 87RI23_0014 (VESTAL)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Toxicology
-
Nelson Marlborough Institute of TechnologyMayo ClinicUnknownLead | Toxicology
-
Renaissance RXSyntactxWithdrawn
-
University of RochesterNational Institute of Environmental Health Sciences (NIEHS)Completed
-
University of LjubljanaCompletedHealthy Volunteers | Liver Function | Dietary Supplement | Kidney Function | Safety / ToxicologySlovenia
-
General Committee of Teaching Hospitals and Institutes...CompletedSubstance Use | Bariatric Surgery | Bariatric Surgery Analgesia | ToxicologyEgypt
-
Johns Hopkins UniversityRTI International; Substance Abuse and Mental Health Services Administration...CompletedCannabis ToxicologyUnited States
-
Johns Hopkins Bloomberg School of Public HealthColumbia University; Sanofi Pasteur, a Sanofi Company; Institute of Epidemiology... and other collaboratorsCompletedInfluenza | Vaccine Response Impaired | Micronutrient Deficiency | Arsenic--Toxicology | Immunologic Disorders Complicating PregnancyBangladesh
Clinical Trials on Urine sampling
-
University Hospital, ToulouseCompletedPneumonia, PneumocystisFrance
-
Brugmann University HospitalRecruiting
-
Centre Hospitalier Universitaire de Saint EtienneWithdrawnAnorexia Nervosa | Eating DisorderFrance
-
University Hospital, BordeauxCompleted
-
Institute of Child HealthGreat Ormond Street Hospital for Children NHS Foundation TrustUnknownLipoma of Spinal CordUnited Kingdom
-
Centre Hospitalier Universitaire de la RéunionRecruitingLipodystrophy | Dunnigan SyndromeRéunion
-
University Hospital Inselspital, BerneCompletedKidney Transplantation | Delayed Graft FunctionGermany, Switzerland
-
Chang Gung Memorial HospitalChang Gung UniversityUnknown
-
CHU de ReimsCompletedCarcinoma | Pancreatic DuctalFrance
-
Turku University HospitalUniversity of TurkuRecruitingProstate Cancer | Prostate HyperplasiaFinland